Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Wade

Showing results (491-500 of 601) with videos related to

Pageof 61
Sort By:
Cancer Chemotherapy and Pharmacology|October 14, 2014
Phase I study of cabazitaxel plus cisplatin in patients with advanced solid tumors: study to evaluate the impact of cytochrome P450 3A inhibitors (aprepitant, ketoconazole) or inducers (rifampin) on the pharmacokinetics of cabazitaxelJohn Sarantopoulos, Alain C Mita, James L Wade, et al.
The Prostate|October 24, 2015
Saracatinib as a metastasis inhibitor in metastatic castration-resistant prostate cancer: A University of Chicago Phase 2 Consortium and DOD/PCF Prostate Cancer Clinical Trials Consortium StudyEdwin M Posadas, Rafi S Ahmed, Theodore Karrison, et al.
Heliyon|November 26, 2019
Baseline data for distribution of contaminants by natural disasters: results from a residential Houston neighborhood during Hurricane Harvey floodingG Bera, K Camargo, J L Sericano, et al.
Journal of Hazardous Materials|May 24, 2019
Early warning sensors for monitoring mercury in waterU Pinaeva, D Lairez, O Oral, et al.
Gynecologic Oncology|February 2, 2010
A phase II study of sorafenib in advanced uterine carcinoma/carcinosarcoma: a trial of the Chicago, PMH, and California Phase II ConsortiaHalla S Nimeiri, Amit M Oza, Robert J Morgan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1994
Phase II trial of edatrexate in patients with advanced pancreatic adenocarcinomaD F Moore, R Pazdur, J L Abbruzzese, et al.
Brain Imaging and Behavior|February 2, 2021
Altered functional network connectivity and working memory dysfunction in adolescents with epilepsyJennifer Vannest, Rupa Radhakrishnan, Ana M Gutierrez-Colina, et al.
Investigational New Drugs|October 11, 2018
Phase I/II study of everolimus combined with mFOLFOX-6 and bevacizumab for first-line treatment of metastatic colorectal cancerG Weldon Gilcrease, David D Stenehjem, Mark L Wade, et al.
Journal of the National Cancer Institute|August 16, 2001
Epoetin treatment of anemia associated with cancer therapy: a systematic review and meta-analysis of controlled clinical trialsJ Seidenfeld, M Piper, C Flamm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2022
Phase I/II Trial of Enzalutamide and Mifepristone, a Glucocorticoid Receptor Antagonist, for Metastatic Castration-Resistant Prostate CancerAnthony V Serritella, Daniel Shevrin, Elisabeth I Heath, et al.
Pageof 61

Showing results (491-500 of 601) with videos related to

Sort By:
Pageof 61
Cancer Chemotherapy and Pharmacology|October 14, 2014
Phase I study of cabazitaxel plus cisplatin in patients with advanced solid tumors: study to evaluate the impact of cytochrome P450 3A inhibitors (aprepitant, ketoconazole) or inducers (rifampin) on the pharmacokinetics of cabazitaxelJohn Sarantopoulos, Alain C Mita, James L Wade, et al.
The Prostate|October 24, 2015
Saracatinib as a metastasis inhibitor in metastatic castration-resistant prostate cancer: A University of Chicago Phase 2 Consortium and DOD/PCF Prostate Cancer Clinical Trials Consortium StudyEdwin M Posadas, Rafi S Ahmed, Theodore Karrison, et al.
Heliyon|November 26, 2019
Baseline data for distribution of contaminants by natural disasters: results from a residential Houston neighborhood during Hurricane Harvey floodingG Bera, K Camargo, J L Sericano, et al.
Journal of Hazardous Materials|May 24, 2019
Early warning sensors for monitoring mercury in waterU Pinaeva, D Lairez, O Oral, et al.
Gynecologic Oncology|February 2, 2010
A phase II study of sorafenib in advanced uterine carcinoma/carcinosarcoma: a trial of the Chicago, PMH, and California Phase II ConsortiaHalla S Nimeiri, Amit M Oza, Robert J Morgan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1994
Phase II trial of edatrexate in patients with advanced pancreatic adenocarcinomaD F Moore, R Pazdur, J L Abbruzzese, et al.
Brain Imaging and Behavior|February 2, 2021
Altered functional network connectivity and working memory dysfunction in adolescents with epilepsyJennifer Vannest, Rupa Radhakrishnan, Ana M Gutierrez-Colina, et al.
Investigational New Drugs|October 11, 2018
Phase I/II study of everolimus combined with mFOLFOX-6 and bevacizumab for first-line treatment of metastatic colorectal cancerG Weldon Gilcrease, David D Stenehjem, Mark L Wade, et al.
Journal of the National Cancer Institute|August 16, 2001
Epoetin treatment of anemia associated with cancer therapy: a systematic review and meta-analysis of controlled clinical trialsJ Seidenfeld, M Piper, C Flamm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2022
Phase I/II Trial of Enzalutamide and Mifepristone, a Glucocorticoid Receptor Antagonist, for Metastatic Castration-Resistant Prostate CancerAnthony V Serritella, Daniel Shevrin, Elisabeth I Heath, et al.
Pageof 61